The assessment of chronic health conditions on work performance, absence, and total economic impact for employers
The assessment of chronic health conditions on work performance, absence, and total economic impact for employers
复制标题
DOI：
10.1097/01.jom.0000166864.58664.29
复制
发表时间：
2005-06-01
影响因子：
3.2
通讯作者：
Berger, ML
中科院分区：
文献类型：
--
作者：
Collins, JJ;Baase, CM;Berger, ML
目的：本研究的目的是确定美国陶氏化学公司（Dow）员工慢性健康状况的患病率并估计其总成本。研究方法：使用斯坦福大学Presenteeism量表，从五个地点的工人收集信息，根据自我报告的“主要”慢性健康状况的工作障碍和缺勤。调查数据与员工人口统计数据，医疗和制药索赔，吸烟状况，生物识别健康风险因素，工资记录和工作类型合并。结果：近65%的受访者报告有一种或多种调查的慢性病。最常见的是过敏、关节炎/关节疼痛或僵硬以及背部或颈部疾病。在4周的时间内，慢性病相关缺勤的时间范围为0.9至5.9小时，在职工作损害的范围为工作能力下降17.8%至36.4%。在调整其他因素后，慢性疾病的存在是报告的工作障碍和缺勤水平的最重要决定因素（P < 0.000）。据估计，慢性病的总成本占陶氏在美国总劳动力成本的10.7%，其中6.8%仅归因于工作障碍。结论：对于所有研究的慢性疾病，与基于绩效的工作损失或“出勤”相关的成本大大超过了缺勤和医疗的综合成本。
Objective: The objective of this study was to determine the prevalence and estimate total costs for chronic health conditions in the U.S. workforce for the Dow Chemical Company (Dow). Methods: Using the Stanford Presenteeism Scale, information was collected from workers at five locations on work impairment and absenteeism based on self-reported "primary" chronic health conditions. Survey data were merged with employee demographics, medical and pharmaceutical claims, smoking status, biometric health risk factors, payroll records, and job type. Results: Almost 65% of respondents reported having one or more of the surveyed chronic conditions. The most common were allergies, arthritis/joint pain or stiffness, and back or neck disorders. The associated absenteeism by chronic condition ranged from 0.9 to 5.9 hours in a 4-week period, and on-the-job work impairment ranged from a 17.8% to 36.4% decrement in ability to function at work. The Presence of a chronic condition was the most important determinant of the reported levels of work impairment and absence after adjusting for other factors (P < 0.000). The total cost of chronic conditions was estimated to be 10.7% of the total labor costs for Dow in the United States, 6.8% was attributable to work impairment alone. Conclusion: For all chronic conditions studied, the cost associated with performance based work loss or "presenteeism" greatly exceeded the combined costs of absenteeism and medical treatment combined.